Elevated serum interferon γ-induced protein 10 kDa is associated with TAFRO syndrome

被引:61
作者
Iwaki, Noriko [1 ,2 ]
Gion, Yuka [1 ]
Kondo, Eisei [3 ]
Kawano, Mitsuhiro [4 ]
Masunari, Taro [5 ]
Moro, Hiroshi [6 ]
Nikkuni, Koji [7 ]
Takai, Kazue [7 ]
Hagihara, Masao [8 ]
Hashimoto, Yuko [9 ]
Yokota, Kenji [10 ]
Okamoto, Masataka [11 ]
Nakao, Shinji [2 ]
Yoshino, Tadashi [1 ]
Sato, Yasuharu [1 ,10 ]
机构
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Okayama, Japan
[2] Kanazawa Univ, Fac Med, Inst Med Pharmaceut & Hlth Sci, Hematol Resp Med, Kanazawa, Ishikawa, Japan
[3] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gen Med, Okayama, Japan
[4] Kanazawa Univ Hosp, Div Rheumatol, Kanazawa, Ishikawa, Japan
[5] Chugoku Cent Hosp, Dept Hematol, Fukuyama, Hiroshima, Japan
[6] Niigata Univ, Div Clin Infect Control & Prevent, Grad Sch Med & Dent Sci, Niigata, Japan
[7] Niigata City Gen Hosp, Div Hematol, Niigata, Japan
[8] Eiju Gen Hosp, Dept Hematol, Tokyo, Japan
[9] Fukushima Med Univ, Dept Diagnost Pathol, Sch Med, Fukushima, Japan
[10] Okayama Univ, Div Pathophysiol, Grad Sch Hlth Sci, Okayama, Japan
[11] Fujita Hlth Univ, Sch Med, Dept Hematol & Med Oncol, Toyoake, Aichi, Japan
基金
日本学术振兴会;
关键词
MULTICENTRIC CASTLEMAN-DISEASE; LYMPH-NODE HYPERPLASIA; HUMAN INTERLEUKIN-6; KAPOSIS-SARCOMA; GROWTH-FACTOR; T-CELLS; IN-VIVO; THROMBOCYTOPENIA; PATHOGENESIS; ANASARCA;
D O I
10.1038/srep42316
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Multicentric Castleman disease (MCD) is a heterogeneous lymphoproliferative disorder. It is characterized by inflammatory symptoms, and interleukin (IL)-6 contributes to the disease pathogenesis. Human herpesvirus 8 (HHV-8) often drives hypercytokinemia in MCD, although the etiology of HHV-8-negative MCD is idiopathic (iMCD). A distinct subtype of iMCD that shares a constellation of clinical features including thrombocytopenia (T), anasarca (A), fever (F), reticulin fibrosis (R), and organomegaly (O) has been reported as TAFRO-iMCD, however the differences in cytokine profiles between TAFRO-iMCD and iMCD have not been established. We retrospectively compared levels of serum interferon gamma-induced protein 10 kDa (IP-10), platelet-derived growth factor (PDGF)-AA, interleukin (IL)-10, and other cytokines between 11 cases of TAFRO-iMCD, 6 cases of plasma cell type iMCD, and 21 healthy controls. During flare-ups, patients with TAFRO-iMCD had significantly higher serum IP-10 and tended to have lower PDGF-AA levels than the other 2 groups. In addition, serum IL-10, IL-23, and vascular endothelial growth factor-A were elevated in both TAFRO-iMCD and iMCD. Elevated serum IP-10 is associated with inflammatory diseases including infectious diseases. There was a strong correlation between high serum IP-10 and the presence of TAFRO-iMCD, suggesting that IP-10 might be involved in the pathogenesis of TAFRO-iMCD.
引用
收藏
页数:7
相关论文
共 34 条
[1]   Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases [J].
Antonelli, Alessandro ;
Ferrari, Silvia Martina ;
Giuggioli, Dilia ;
Ferrannini, Ele ;
Ferri, Clodoveo ;
Fallahi, Poupak .
AUTOIMMUNITY REVIEWS, 2014, 13 (03) :272-280
[2]   HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION [J].
ASSICOT, M ;
GENDREL, D ;
CARSIN, H ;
RAYMOND, J ;
GUILBAUD, J ;
BOHUON, C .
LANCET, 1993, 341 (8844) :515-518
[3]  
CASTLEMAN B, 1956, CANCER-AM CANCER SOC, V9, P822, DOI 10.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO
[4]  
2-4
[5]  
Chadburn A, 1997, CANCER-AM CANCER SOC, V80, P788, DOI 10.1002/(SICI)1097-0142(19970815)80:4<788::AID-CNCR18>3.0.CO
[6]  
2-P
[7]   IL-6 Triggers IL-21 production by human CD4+ T cells to drive STAT3-dependent plasma cell differentiation in B cells [J].
Diehl, Sean A. ;
Schmidlin, Heike ;
Nagasawa, Maho ;
Blom, Bianca ;
Spits, Hergen .
IMMUNOLOGY AND CELL BIOLOGY, 2012, 90 (08) :802-811
[8]   Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities [J].
Eddahri, Fouad ;
Denanglaire, Sebastien ;
Bureau, Fabrice ;
Spolski, Rosanne ;
Leonard, Warren J. ;
Leo, Oberdan ;
Andris, Fabienne .
BLOOD, 2009, 113 (11) :2426-2433
[9]   HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy [J].
Fajgenbaum, David C. ;
van Rhee, Frits ;
Nabel, Christopher S. .
BLOOD, 2014, 123 (19) :2924-2933
[10]   A SYSTEMIC LYMPHOPROLIFERATIVE DISORDER WITH MORPHOLOGIC FEATURES OF CASTLEMANS DISEASE - CLINICAL FINDINGS AND CLINICOPATHOLOGIC CORRELATIONS IN 15 PATIENTS [J].
FRIZZERA, G ;
PETERSON, BA ;
BAYRD, ED ;
GOLDMAN, A .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (09) :1202-1216